Sameer Al-Mehmadi

Sameer Al-Mehmadi

UNVERIFIED PROFILE

Are you Sameer Al-Mehmadi?   Register this Author

Register author
Sameer Al-Mehmadi

Sameer Al-Mehmadi

Publications by authors named "Sameer Al-Mehmadi"

Are you Sameer Al-Mehmadi?   Register this Author

4Publications

72Reads

46Profile Views

A Review of Investigations for Patients With Tuberous Sclerosis Complex Who Were Referred to the Tuberous Sclerosis Clinic at The Hospital for Sick Children: Identifying Gaps in Surveillance.

Pediatr Neurol 2020 Jan 4;102:44-48. Epub 2019 Jul 4.

Division of Neurology, Department of Pediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pediatrneurol.2019.06.018DOI Listing
January 2020

The role of surgery in refractory epilepsy secondary to polymicrogyria in the pediatric population.

Epilepsia 2018 10 11;59(10):1982-1996. Epub 2018 Sep 11.

Division of Neurosurgery, The Hospital for Sick Children, Department of Surgery, The University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/epi.14556DOI Listing
October 2018

A prospective open-label trial of a CBD/THC cannabis oil in dravet syndrome.

Ann Clin Transl Neurol 2018 Sep 1;5(9):1077-1088. Epub 2018 Aug 1.

Division of Neurology the Hospital for Sick Children Toronto Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acn3.621DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6144444PMC
September 2018

FHF1 (FGF12) epileptic encephalopathy.

Neurol Genet 2016 Dec 28;2(6):e115. Epub 2016 Oct 28.

Program in Genetics and Genome Biology and Division of Neurology (S.A.-M., B.A.M.), Department of Paediatrics, The Hospital for Sick Children, and University of Toronto, Ontario, Canada; Institute of Genetic Medicine (M.S.), International Centre for Life, Pediatric Neurology (V.R.), Newcastle General Hospital, UK; Center for Human Genetics (S.D., K.D.), UH Case Medical Center, Cleveland, OH; Department of Molecular and Human Genetics (F.X., Y.Y., J.A.R.), Baylor College of Medicine, Houston, TX; Baylor Miraca Genetics Laboratories (F.X., Y.Y.), Houston, TX; The Deciphering Developmental Disorders (DDD) Study, Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK; Division of Neurology (P.C.), CHUM Notre-Dame, Hospital University of Montreal, Quebec, Canada; Department of Pediatrics (J.L.M., P.M.C.), Department of Neurosciences (J.L.M., P.M.C.), Université de Montréal, Québec, Canada; and CHU Sainte-Justine Research Center (J.L.M., F.A.H., P.M.C.), Montreal, Quebec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/NXG.0000000000000115DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087254PMC
December 2016